Skip to main content
. 2020 Sep 16;3:34–38. doi: 10.1016/j.sopen.2020.08.001

Table 2.

Secondary outcomes

No ASI (n = 87) ASI (n = 36) P value
Major adverse cardiovascular events 15% (13) 14% (5) 1
Infections 9% (8) 22% (8) .10